Resolution of primary amyloidosis by melphalan and prednisolone: A case report

Clinical Nephrology

Volumn 63, Issue 3, 2005, Pages 215-220

  Nakayama, M ^a   Kashiwagi, M ^b   Katafuchi, R ^b   Hori, K ^b   Hayashi, S ^b   Fujimi, S ^b  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^b FUKUOKA RED CROSS HOSPITAL   (Japan)

Author keywords

Melphalan; Prednisolone; Primary amyloidosis

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; AMYLOID; CREATININE; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; MELPHALAN; PREDNISOLONE;

ADULT; AMYLOIDOSIS; ARTICLE; ASCITES; BLOOD VESSEL; CASE REPORT; GLOMERULUS; HEMODIALYSIS; HEPATOMEGALY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; LABORATORY TEST; LIVER BIOPSY; MAINTENANCE THERAPY; MALE; MEDICAL ASSESSMENT; NEPHROTIC SYNDROME;

EID: 14944375184     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP63215     Document Type: Article

References (20)

1. Benson ND 1986 Treatment of amyloidosis with melphalan, prednisone, and colchicine. Arthritis Rheum 29: 683-687
2. Cohen HJ, Lessin LS, Hallal J, Burkholder P 1975 Resolution of primary amyloidosis during chemotherapy: studies in a patient with nephrotic syndrome. Ann Intern Med 82: 466-473
3. Falck HM, Tornroth T, Skrifvars B, Wegelius O 1979 Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand 205: 615-656
4. Gertz MA, Kyle RA 1986 Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of literature. Mayo Clin Proc 61: 218-223
5. Gertz MA, Kyle RA, O'Fallom WM 1992 Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients. Arch Intern Med 152: 2245-2250
6. Gianni L, Bellotti V, Gianni AM, Merlini G 1995 New drug therapy of amyloidoses: resorption of AL-type deposits with 4′-iodo-4′-deoxydoxorubicin. Blood 86: 855-861
7. Hajzok O, Tomik F, Hajzokova M 1976 Amyloidosis in rheumatoid arthritis. A study of 48 histologically confirmed cases. Z Rheum 35: 356-362
8. Jones NF, Hilton PJ, Tighe JR, Hobbs JR 1972 Treatment of "primary" renal amyloidosis with melphalan. Lancet 2: 616-619
9. Karsenty G, Ulmann A, Droz D, Carnol F, Grünfeld JP 1985 Clinical and histological resolution of systemic amyloidosis after renal cell carcinoma removal. Nephron 40: 232-234
10. Kedar I, Sohar E, Gafni J 1974 Demonstration of amyloid-degrading activity in normal human serum. Proc Soc Exp Biol Med 145: 343-345
11. Kyle RA, Gertz MA 1995 Primary systemic amyloidosis. Clinical and laboratory features in 474 cases. Semin Hematol 32: 45-59
12. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM 1997 A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, predisone, and colchicine. N Engl J Med 336: 1202-1207
13. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM 1999 Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood 93: 1062-1066
14. Kyle RA, Greipp PR 1978 Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo. Blood 52: 818-827
15. Kyle RA, Pierre RV, Bayrd ED 1974 Primary amyloidosis and acute leukemia associated with melphalan therapy. Blood 44: 333-337
16. Kyle RA, Wagoner RD, Holley KE 1982 Primary systemic amyloidosis: resolution of the nephrotic syndrome with melphalan and prednisone. Arch Intern Med 142: 1445-1447
17. Lowenstein J, Gallo G 1970 Remission of the nephrotic syndrome in renal amyloidosis. N Engl J Med 282: 128-131
18. Merlini G 1995 Treatment of primary amyloidosis. Semin Hematol 32: 60-79
19. Waldenström H 1928 Formation and disappearance of amyloid in man. Acta Chir Scand 63: 479-530
20. Watanabe T, Saniter T 1975 Morphological and clinical features of renal amyloidosis. Virchows Arch Pathol Anatom 366: 125-135